NRC Health announced that Shane Harrison resigned as Chief Financial Officer and principal financial officer on August 7, 2026, to pursue an outside professional opportunity. His resignation becomes effective on August 28, 2026. The company has initiated a search for a replacement CFO. NRC Health operates in the healthcare technology industry, providing workforce management software solutions.

NRC Health reported second quarter 2026 financial results, announcing Total Recurring Contract Value (TRCV) of $151.9 million, an 11% year-over-year increase. Total revenue reached $35.4 million, up 4% from the prior year. The company reported a GAAP net loss of $3.3 million, or $0.15 per diluted share, while Adjusted Net Income was $6.9 million, or $0.31 per diluted share. Adjusted EBITDA stood at $9.4 million, representing a 27% margin. Additionally, the Board declared a quarterly cash dividend of $0.16 per share, payable on October 9, 2026, to shareholders of record as of September 25, 2026. NRC Health operates in the healthcare industry, providing experience improvement solutions, market research, and governance services to healthcare organizations.

At its June 23, 2026, annual meeting, National Research Corporation stockholders approved several significant amendments to the company's certificate of incorporation and bylaws. These changes included removing supermajority voting requirements, eliminating restrictions on the removal of directors without cause, and lowering the voting threshold required for stockholder action by written consent. The amended and restated charter became effective on June 24, 2026. Additionally, the company elected seven directors, ratified KPMG LLP as its independent auditor, and received advisory approval for executive compensation. NRC Health provides healthcare performance improvement and data analytics services.